Tayyaba Hasan, Ph.D.
Professor, Department of Dermatology, Harvard Medical School
Biochemist, Wellman Center for Photomedicine, Massachusetts General Hospital
Director, Office for Research Career Development, Massachusetts General Hospital
Contact Info
Tayyaba Hasan
Massachusetts General Hospital
40 Blossom Street
Boston, MA, 02114
Mailstop: BAR 314
Phone: 617-726-6996
Fax: 617-726-8566
thasan@partners.org
Administrative Assistant
Dermatology
Massachusetts General Hospital
40 Blossom Street
Boston, MA, 02114
Phone: 617-726-6856
Fax: 617-726-8566
edavis7@partners.org
Massachusetts General Hospital
40 Blossom Street
Boston, MA, 02114
Mailstop: BAR 314
Phone: 617-726-6996
Fax: 617-726-8566
thasan@partners.org
Assistant
Bets DavisAdministrative Assistant
Dermatology
Massachusetts General Hospital
40 Blossom Street
Boston, MA, 02114
Phone: 617-726-6856
Fax: 617-726-8566
edavis7@partners.org
DF/HCC Program Affiliation
Gynecologic CancerResearch Abstract
Activation of certain chemicals with light leads to photochemical processes that involve the generation of free radicals and excited oxygen species. These molecular species are capable of destroying cells and tissues at or near the areas of photochemistry initiation. An advantage of this approach is that it provides the potential of double selectivity; first, due to the confinement of sites of illumination, and second, due to preferential localization of the activatable chemicals in many neoplastic tissues. Selectivity is further enhanced by delivering the photoactivatable molecules via vehicles such as antibodies and liposomes. The mechanisms of tissue destruction by photochemical processes are different from those used by most cheomtherapeutic drugs. This provides the possibility of using targeted photocemistry in combination with conventional chemotherapy to: 1) destroy cells that are resistant (acquired or intrinsic), and 2) achieve better (broader) tumor response due to the more varied arsenal for attack provided by the combination of photochemical and chemotherapeutic approaches. The best known biomedical application of photochemical targeting is photodynamic therapy (PDT). Research in our laboratories is focused on the mechanistic, therapeutic, and imaging aspects of photobiology to cancer.Publications
- del Carmen MG, Rizvi I, Chang Y, Moor AC, Oliva E, Sherwood M, Pogue B, Hasan T.Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo.J Natl Cancer Inst 2005 Oct 19;97(20):1516-24.
16234565 - Savellano MD, Hasan T.Photochemical targeting of epidermal growth factor receptor: a mechanistic study.Clin Cancer Res 2005 Feb 15;11(4):1658-68.
15746071 - Chen B, Pogue BW, Zhou X, O'Hara JA, Solban N, Demidenko E, Hoopes PJ, Hasan T.Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.Clin Cancer Res 2005 Jan 15;11(2 Pt 1):720-7.
15701861




